INSUBCONTINENT EXCLUSIVE:
Manas Jaiswal of manasjaiswal.com has a buy call on Dr
with a target price of Rs 3000
The current market price of Dr
Time period given by the analyst is Intra Day when Dr
price can reach the defined target
Manas Jaiswal recommended to keep stoploss at Rs 2885
Reddy's Laboratories Ltd., incorporated in 1984, has a market cap of Rs 48560.17 crore.
Dr
key Products/Revenue Segments include Pharmaceuticals which contributed Rs 9246.80 Crore to Sales Value (98.79 % of Total Sales), Licence
Fees which contributed Rs 55.80 Crore to Sales Value (0.59 % of Total Sales), Spent Chemicals which contributed Rs 29.70 Crore to Sales
Value (0.31 % of Total Sales), Scrap which contributed Rs 16.00 Crore to Sales Value (0.17 % of Total Sales) and Other Operating Revenue
which contributed Rs 11.00 Crore to Sales Value (0.11 % of Total Sales)for the year ending 31-Mar-2018
For the quarter ended 31-12-2018, the company has reported a Consolidated sales of Rs 3786.10 Crore, up 2.70 % from last quarter Sales of
Rs 3686.60 Crore and down -.52 % from last year same quarter Sales of Rs 3806.00 Crore Company has reported net profit after tax of Rs
491.40 Crore in latest quarter
The company’s top management includes Dr.Bruce L A Carter, Dr.Omkar Goswami, Mr.Allan Oberman, Mr.Anupam Puri, Mr.Bharat N Doshi, Mr.G V
Prasad, Mr.K Satish Reddy, Mr.Leo Puri, Mr.Prasad R Menon, Mr.Sridar Iyengar, Ms.Kalpana Morparia, Ms.Shikha Sanjaya Sharma
Company has S R Batliboi Associates LLP as its auditoRs As on 31-03-2019, the company has a total of 166,065,948 shares outstanding.